The ECM and tissue architecture are major determinants of early invasion mediated by E-cadherin dysfunction.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
08 11 2023
Historique:
received: 20 01 2023
accepted: 18 10 2023
medline: 9 11 2023
pubmed: 8 11 2023
entrez: 8 11 2023
Statut: epublish

Résumé

Germline mutations of E-cadherin cause Hereditary Diffuse Gastric Cancer (HDGC), a highly invasive cancer syndrome characterised by the occurrence of diffuse-type gastric carcinoma and lobular breast cancer. In this disease, E-cadherin-defective cells are detected invading the adjacent stroma since very early stages. Although E-cadherin loss is well established as a triggering event, other determinants of the invasive process persist largely unknown. Herein, we develop an experimental strategy that comprises in vitro extrusion assays using E-cadherin mutants associated to HDGC, as well as mathematical models epitomising epithelial dynamics and its interaction with the extracellular matrix (ECM). In vitro, we verify that E-cadherin dysfunctional cells detach from the epithelial monolayer and extrude basally into the ECM. Through phase-field modelling we demonstrate that, aside from loss of cell-cell adhesion, increased ECM attachment further raises basal extrusion efficiency. Importantly, by combining phase-field and vertex model simulations, we show that the cylindrical structure of gastric glands strongly promotes the cell's invasive ability. Moreover, we validate our findings using a dissipative particle dynamics simulation of epithelial extrusion. Overall, we provide the first evidence that cancer cell invasion is the outcome of defective cell-cell linkages, abnormal interplay with the ECM, and a favourable 3D tissue structure.

Identifiants

pubmed: 37938268
doi: 10.1038/s42003-023-05482-x
pii: 10.1038/s42003-023-05482-x
pmc: PMC10632478
doi:

Substances chimiques

Cadherins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1132

Subventions

Organisme : Marie Curie
ID : 80113 (Scientia fellowship)
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Eur J Hum Genet. 2013 Mar;21(3):301-9
pubmed: 22850631
Nat Rev Cancer. 2004 Feb;4(2):118-32
pubmed: 14964308
Biophys J. 2020 May 19;118(10):2549-2560
pubmed: 32333862
J Cell Sci. 2001 Feb;114(Pt 4):629-41
pubmed: 11171368
PLoS Comput Biol. 2020 Dec 10;16(12):e1008411
pubmed: 33301528
Lancet Oncol. 2020 Aug;21(8):e386-e397
pubmed: 32758476
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Prog Mol Biol Transl Sci. 2013;116:337-59
pubmed: 23481202
J Math Biol. 2012 Sep;65(3):441-63
pubmed: 21898111
ACS Biomater Sci Eng. 2019;5(8):3766-3787
pubmed: 32953985
J Phys Condens Matter. 2020 May 07;32(31):314001
pubmed: 32378515
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14770-5
pubmed: 25258412
J Cell Biol. 1990 Apr;110(4):1427-38
pubmed: 2324200
PLoS Comput Biol. 2012;8(5):e1002512
pubmed: 22615550
Prog Biophys Mol Biol. 2013 Nov;113(2):299-326
pubmed: 24120733
Nat Cell Biol. 2009 Apr;11(4):460-7
pubmed: 19287376
Nat Rev Cancer. 2014 Jul;14(7):495-501
pubmed: 24943812
Phys Rev Lett. 2006 Nov 24;97(21):218101
pubmed: 17155774
J Pathol. 2012 Jan;226(2):185-99
pubmed: 22006671
Gastroenterology. 2001 Dec;121(6):1348-53
pubmed: 11729114
Nat Rev Mol Cell Biol. 2014 Dec;15(12):771-85
pubmed: 25370693
Gastric Cancer. 2022 Jan;25(1):124-137
pubmed: 34486077
Nature. 1998 Mar 26;392(6674):402-5
pubmed: 9537325
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33658384
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129
pubmed: 20457567
Curr Opin Cell Biol. 1995 Oct;7(5):619-27
pubmed: 8573335
Gut. 2004 Jun;53(6):814-20
pubmed: 15138207
Hum Mol Genet. 2015 Oct 15;24(20):5891-900
pubmed: 26246502
Front Cell Dev Biol. 2022 Mar 24;10:767688
pubmed: 35399530
J Infect Dis. 2022 Dec 13;226(12):2226-2237
pubmed: 36173814
Biophys J. 1996 Jan;70(1):358-69
pubmed: 8770212
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188719
pubmed: 35307354
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1152-1161
pubmed: 30617074
J Cell Sci. 2013 Jan 15;126(Pt 2):393-401
pubmed: 23525005
Cell. 2018 Dec 13;175(7):1769-1779.e13
pubmed: 30392960
Biophys J. 1996 Sep;71(3):1348-9
pubmed: 8874009
Curr Biol. 2007 Dec 18;17(24):2095-104
pubmed: 18082406
Hum Mol Genet. 2008 Nov 15;17(22):3566-76
pubmed: 18772194
Cell. 1996 Feb 9;84(3):345-57
pubmed: 8608588
Cell. 1997 Jan 10;88(1):39-48
pubmed: 9019403
PLoS One. 2013 Nov 18;8(11):e80516
pubmed: 24260407
Nat Cell Biol. 2020 Sep;22(9):1103-1115
pubmed: 32839548
Nat Cell Biol. 2015 May;17(5):533-9
pubmed: 25925582
J Cell Sci. 2020 Jul 6;133(13):
pubmed: 32467325
Cells. 2020 Feb 08;9(2):
pubmed: 32046329
J Pathol. 2004 Jun;203(2):681-7
pubmed: 15141383
J Pathol. 2008 Nov;216(3):286-94
pubmed: 18825658
Nat Mater. 2016 Aug;15(8):856-62
pubmed: 27043781
Nat Commun. 2022 Jan 11;13(1):218
pubmed: 35017535
Cell Mol Life Sci. 2008 Nov;65(23):3756-88
pubmed: 18726070
PLoS Comput Biol. 2016 Jan 21;12(1):e1004591
pubmed: 26795950
JAMA Oncol. 2015 Apr;1(1):23-32
pubmed: 26182300
Cancers (Basel). 2022 May 29;14(11):
pubmed: 35681670
J Gen Physiol. 1997 Jul;110(1):1-10
pubmed: 9234166
Nat Cell Biol. 2013 Jul;15(7):751-62
pubmed: 23792690
Development. 2019 Dec 4;146(23):
pubmed: 31784457
J Cell Sci. 2014 Aug 1;127(Pt 15):3331-46
pubmed: 24895403
Annu Rev Cell Dev Biol. 2010;26:721-44
pubmed: 20604711
Science. 2022 Jan 07;375(6576):eaaw9021
pubmed: 34990240
Nat Rev Mol Cell Biol. 2011 May;12(5):308-19
pubmed: 21508987
Lancet Oncol. 2015 Feb;16(2):e60-70
pubmed: 25638682
Phys Rev Lett. 2000 May 1;84(18):4244-7
pubmed: 10990656
Biochim Biophys Acta. 2012 Dec;1826(2):297-311
pubmed: 22613680
Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Sep;88(3):034702
pubmed: 24125388
iScience. 2021 Oct 12;24(11):103252
pubmed: 34755092
Cell. 2012 Dec 21;151(7):1513-27
pubmed: 23260139
Curr Opin Struct Biol. 2015 Aug;33:61-7
pubmed: 26282924
JAMA. 2007 Jun 6;297(21):2360-72
pubmed: 17545690
Curr Opin Cell Biol. 2020 Oct;66:11-18
pubmed: 32416466
Am J Surg Pathol. 2008 Jun;32(6):799-809
pubmed: 18391748
PLoS One. 2012;7(4):e33501
pubmed: 22539943
Hum Mol Genet. 2003 Mar 1;12(5):575-82
pubmed: 12588804

Auteurs

Soraia Melo (S)

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ipatimup - Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, Porto, Portugal.

Pilar Guerrero (P)

Departamento de Matemáticas and Grupo Interdisciplinar de Sistemas Complejos (GISC), Universidad Carlos III de Madrid, Leganés, Spain.

Maurício Moreira Soares (M)

Oslo Center for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway.

José Rafael Bordin (JR)

Department of Physics, Institute of Physics and Mathematics, Federal University of Pelotas, Capão do Leão, Rio Grande do Sul, Brazil.

Fátima Carneiro (F)

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ipatimup - Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, Porto, Portugal.
Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.

Patrícia Carneiro (P)

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ipatimup - Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, Porto, Portugal.

Maria Beatriz Dias (MB)

CISUC, Department of Informatics Engineering, University of Coimbra, Coimbra, Portugal.

João Carvalho (J)

CFisUC, Department of Physics, University of Coimbra, Coimbra, Portugal.

Joana Figueiredo (J)

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. jfigueiredo@i3s.up.pt.
Ipatimup - Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, Porto, Portugal. jfigueiredo@i3s.up.pt.
Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal. jfigueiredo@i3s.up.pt.

Raquel Seruca (R)

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ipatimup - Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, Porto, Portugal.
Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.

Rui D M Travasso (RDM)

CFisUC, Department of Physics, University of Coimbra, Coimbra, Portugal. ruit@uc.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH